The technique could be used to detect outbreaks while they're happening.
An antimicrobial stewardship program (ASP) at a long-term acute care hospital in Detroit improved antimicrobial prescribing practices, reduced costs, and has proven to be sustainable, researchers report today in the American Journal of Infection Control.
Three studies presented at IDWeek 2017 in San Diego last week focused on the emerging colistin-resistance gene MCR-1 in the United States.
Iranian scientists report a 7.6% prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in almost 500 hospital food samples they tested, and the bacteria had high levels of resistance to other antibiotics, as well, according to a study yesterday in Antimicrobial Resistance & Infection Control.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV in Al Hofuf late last week, one of which was fatal. These are the first cases reported by the MOH in 10 days.
On Sep 21, the MOH confirmed that a 48-year-old Saudi man with direct camel contact was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) infection after presenting with MERS symptoms. He is in stable condition.
More funding, public health efforts, and surveillance are needed to ensure responsible use of antimicrobials in food animals and humans, Maria Helena Semedo, deputy director-general with the United Nations (UN) Food and Agriculture Organization (FAO), said yesterday. She was speaking to participants at a UN General Assembly event on Antimicrobial Resistance (AMR).
A study today involving 111 patients found that early fecal microbiota transplantation (FMT) dramatically improves survival in severe Clostridium difficile infections (CDIs).
An experimental drug that belongs to a new class of antibiotics showed promise in lab tests against multidrug-resistant (MDR) gram-negative bacteria, and was protective against the bacterium that causes plague in mice, according to a study yesterday in mBio.
A study today in Genome Biology suggests methicillin-resistant Staphylococcus aureus (MRSA) emerged several years before methicillin was used to treat S aureus infections.
A study yesterday in Antimicrobial Resistance and Infection Control found that patients with methicillin-resistant Staphylococcus aureus (MRSA) in Norway have longer hospital stays and incur higher costs than those without MRSA.
